CorMedix, Inc. (CRMD)
7.585
+0.10
(+1.40%)
USD |
NASDAQ |
Apr 30, 16:00
7.585
0.00 (0.00%)
After-Hours: 20:00
CorMedix EPS Diluted (Quarterly) : 0.1493 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Altimmune, Inc. | -0.2719 |
| Theravance Biopharma, Inc. | 1.150 |
| REGENXBIO, Inc. | -1.298 |
| Janux Therapeutics, Inc. | -0.514 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.02M |
| Revenue (Quarterly) | 128.62M |
| Total Expenses (Quarterly) | 114.60M |
| Enterprise Value | 591.02M |
| Gross Profit Margin (Quarterly) | 83.43% |
| Profit Margin (Quarterly) | 10.90% |
| Earnings Yield | 26.15% |
| Operating Earnings Yield | 24.66% |
| Normalized Earnings Yield | 26.26 |